Interest-Based Ads

Advertising Cookies: We would like to set third-party advertising cookies on your browser for this health-related website to help us serve relevant health-related advertisements to you about our products or services when you visit other websites. For more information, visit our Privacy Policy. Do you want to set these advertising cookies on this browser?

Patients HCP

This site is for US residents only.

Prescribing Info, Including Patient Info

Site Map

Home
About Ph+ CML-CP
- Understanding Ph+ CML in Chronic Phase
- Treatment Milestones
- Monitoring Ph+ CML in Chronic Phase
- Glossary
About SCEMBLIX
Side Effects
- Common and Serious Side Effects of SCEMBLIX
Patient Support
- Savings & Support
- Sign Up to Learn More
- Helpful Resources
- Medicare Extra Help

Important Safety Information

Before taking SCEMBLIX, tell your doctor about all your medical conditions, including if you:

have a history of inflammation of your pancreas (pancreatitis)
have a history of heart problems or blood clots in your arteries and veins (types of blood vessels)
are pregnant or plan to become pregnant. SCEMBLIX can harm your unborn baby ...

Approved Uses

SCEMBLIX is a prescription medicine used to treat adults with:

Newly diagnosed or previously treated Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)
- The approval of SCEMBLIX in patients newly diagnosed is based on a study that measured major molecular response (MMR) rate. There are ongoing studies to confirm the clinical benefit of SCEMBLIX for this use and how SCEMBLIX works over a longer period of time
Ph+ CML in CP with the T315I mutation

It is not known if SCEMBLIX is safe and effective in children.

Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USES